Pharmaceutical Impurities

image(10)

Pharmaceutical Impurities

Pharmaceutical impurities and reference standards play a crucial role in ensuring the quality, safety, and efficacy of drug substances and formulations. Impurities are unintended substancesthat may arise during the synthesis, storage, or degradation of an API. Regulatory authorities mandate stringent impurity profiling and qualification to meet global compliance standards. Reference standards, on the other hand, serve as highly pure benchmarks for analytical testing, helping researchers and manufacturers confirm the identity, purity, and potency of pharmaceutical compounds. Their accurate characterization is essential for maintaining consistency and reliability in drug development and production.

At Zasya Life Sciences, we specialize in the custom synthesis of pharmaceutical impurities, offering tailored solutions to meet the unique needs of our clients. Our team of skilled scientists, backed by deep expertise in synthetic chemistry, provides high-quality impurities that are often challenging to source in the market. Whether it’s process-related, degradation, or API intermediates, we ensure the highest purity and analytical characterization to support regulatory submissions and R&D requirements.

Zasya extends its capabilities to peptide impurities, offering them exclusively through custom synthesis. Our expertise in complex molecular modifications allows us to design and synthesize peptide-related impurities that align with stringent research and quality control needs. With a commitment to innovation and excellence, we aim to be a trusted partner in impurity profiling, delivering superior-quality solutions with precision and reliability.

Eliglustat Impurity Fostemsavir Olsalazine Tegoprazan Tovorafenib ZLS
5-chloro-4-(trifluoromethyl)pyridin-2-amine hydrochloride
5-chloro-4-(trifluoromethyl)pyridin-2-amine hydrochloride

CAS No: 1095824-77-3

Mol.F: C6H5Cl2F3N2

Mol.Wt: 233.02

Inv. Status: In Stock

N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)-2-(1-(hydroxyimino)ethyl)thiazole-5-carboxamide
N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)-2-(1-(hydroxyimino)ethyl)thiazole-5-carboxamide

CAS No: 1095823-58-7

Mol.F: C12H8ClF3N4O2S

Mol.Wt: 364.73

Inv. Status: In Stock

2-acetyl-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
2-acetyl-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide

CAS No: 1095825-46-9

Mol.F: C12H7ClF3N3O2S

Mol.Wt: 349.71

Inv. Status: In Stock

2-acetylthiazole-5-carboxylic acid
2-acetylthiazole-5-carboxylic acid

CAS No: 1095824-76-2

Mol.F: C6H5NO3S

Mol.Wt: 171.17

Inv. Status: In Stock

2-(2-methyl-1,3-dioxolan-2-yl)thiazole-5-carboxylic acid
2-(2-methyl-1,3-dioxolan-2-yl)thiazole-5-carboxylic acid

CAS No: 1909309-55-2

Mol.F: C8H9NO4S

Mol.Wt: 215.22

Inv. Status: In Stock

2-(2-methyl-1,3-dioxolan-2-yl)thiazole
2-(2-methyl-1,3-dioxolan-2-yl)thiazole

CAS No: 24295-06-5

Mol.F: C7H9NO2S

Mol.Wt: 171.21

Inv. Status: In Stock

1-(thiazol-2-yl)ethanone
1-(thiazol-2-yl)ethanone

CAS No: 24295-03-2

Inv. Status: In Stock